PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Demyelinating Diseases Unit, Jiménez Diaz Foundation University Hospital, Madrid, Spain.\', \'Demyelinating Diseases Unit, La Princesa University Hospital, Madrid, Spain.\', \'Multiple Sclerosis Unit, Ramón y Cajal University Hospital, Madrid, Spain.\', \'Department of Neurology, Department of Medicine, Faculty of Medicine, San Carlos Clinical Hospital, Complutense University of Madrid and San Carlos Institute for Health Research, Madrid, Spain.\', \'Neuroimmunology and Multiple Sclerosis Unit, La Paz University Hospital, Madrid, Spain.\', \'Infanta Leonor University Hospital, Madrid, Spain.\', \'Alcorcón Foundation University Hospital, Madrid, Spain.\', \'Neuroimmunology Unit, Puerta de Hierro University Hospital, Madrid, Spain.\', \'Demyelinating Diseases Unit, University Hospital of Getafe, Madrid, Spain.\', \'Severo Ochoa University Hospital, Madrid, Spain.\', \'Demyelinating Diseases Unit, Gregorio Marañón General University Hospital, Madrid, Spain.\', \'Henares University Hospital, Madrid, Spain.\', \'Central Defense Hospital \'Gómez Ulla,\', Madrid, Spain.\', \'Torrejón University Hospital, Madrid, Spain.\', \'Complutense University of Madrid, Madrid, Spain.\', \'University of Edinburgh, Edinburgh, Scotland.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1111/ene.14990
?:doi
?:hasPublicationType
?:journal
  • European journal of neurology
is ?:pmid of
?:pmid
?:pmid
  • 34152073
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.65
?:rankingScore_hIndex
  • 109
?:title
  • Risk and outcomes of COVID-19 in patients with multiple sclerosis.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all